Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1982-10-29
pubmed:abstractText
The majority of hybridomas we have characterized against Epstein-Barr virions react with the major glycoproteins gp350 and gp220 (gp350/220). One of these antibodies, ID4C-1, neutralizes virus infection in vitro. The presence of gp350/220 on the viral envelope could be confirmed directly by immunoelectron microscopy. We used lectin affinity (ricin) and immunoaffinity (ID4C-1) to purify gp350/220 and show that this material is able to induce potent virus-neutralizing antibodies. Absorption of four human and one rabbit anti-Epstein-Barr virus sera with purified gp350/220 suggests that this is the primary component responsible for generating neutralizing antibodies in vivo.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/6287039-1102604, http://linkedlifedata.com/resource/pubmed/commentcorrection/6287039-11905208, http://linkedlifedata.com/resource/pubmed/commentcorrection/6287039-165518, http://linkedlifedata.com/resource/pubmed/commentcorrection/6287039-167182, http://linkedlifedata.com/resource/pubmed/commentcorrection/6287039-176452, http://linkedlifedata.com/resource/pubmed/commentcorrection/6287039-195004, http://linkedlifedata.com/resource/pubmed/commentcorrection/6287039-217544, http://linkedlifedata.com/resource/pubmed/commentcorrection/6287039-221591, http://linkedlifedata.com/resource/pubmed/commentcorrection/6287039-228070, http://linkedlifedata.com/resource/pubmed/commentcorrection/6287039-229261, http://linkedlifedata.com/resource/pubmed/commentcorrection/6287039-4109105, http://linkedlifedata.com/resource/pubmed/commentcorrection/6287039-4917014, http://linkedlifedata.com/resource/pubmed/commentcorrection/6287039-6059570, http://linkedlifedata.com/resource/pubmed/commentcorrection/6287039-6154378, http://linkedlifedata.com/resource/pubmed/commentcorrection/6287039-6161964, http://linkedlifedata.com/resource/pubmed/commentcorrection/6287039-6162806, http://linkedlifedata.com/resource/pubmed/commentcorrection/6287039-6177865, http://linkedlifedata.com/resource/pubmed/commentcorrection/6287039-6248876, http://linkedlifedata.com/resource/pubmed/commentcorrection/6287039-6254017, http://linkedlifedata.com/resource/pubmed/commentcorrection/6287039-6254073, http://linkedlifedata.com/resource/pubmed/commentcorrection/6287039-6268807, http://linkedlifedata.com/resource/pubmed/commentcorrection/6287039-89099, http://linkedlifedata.com/resource/pubmed/commentcorrection/6287039-92577
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0022-538X
pubmed:author
pubmed:issnType
Print
pubmed:volume
43
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
730-6
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1982
pubmed:articleTitle
Identification and isolation of the main component (gp350-gp220) of Epstein-Barr virus responsible for generating neutralizing antibodies in vivo.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't